Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ursula Klanke"'
Autor:
Mike Gajdiss, Ricarda Maria Schmithausen, Esther Sib, Heike Müller, Katja Kehl, Norman Hembach, Nicole Zacharias, Franziska Lenz-Plet, Marijo Parcina, Thomas Schwartz, Christiane Schreiber, Ursula Klanke, Anna Schallenberg, Mykhailo Savin, Vanessa Barabasch, Martin Exner, Gabriele Bierbaum, Judith Kreyenschmidt, Cathrin Albert
Publikováno v:
The science of the total environment, 746, Art.-Nr.: 140894
Multidrug-resistant bacteria cause difficult-to-treat infections and pose a risk for modern medicine. Sources of multidrug-resistant bacteria include hospital, municipal and slaughterhouse wastewaters. In this study, bacteria with resistance to 3rd g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f576f30fc5a28ad8a4c69159b6fb288e
https://publikationen.bibliothek.kit.edu/1000129735
https://publikationen.bibliothek.kit.edu/1000129735
Autor:
Esther Sib, Anna Schallenberg, Franziska Lenz-Plet, Ricarda Maria Schmithausen, Marijo Parcina, Steffen Engelhart, Heike Müller, Vanessa Barabasch, Christiane Schreiber, Nicole Zacharias, Martin Exner, Christian Timm, Cathrin Albert, Ursula Klanke, Gabriele Bierbaum, Mike Gajdiss
Publikováno v:
FEMS microbiology ecology. 94(5)
Carbapenem antibiotics constitute the mainstay therapy of nosocomial infections with extended spectrum beta-lactamase producing Gram-negative bacteria; however, resistance against these compounds is increasing. This study was designed to demonstrate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8173056bf085931de374a61a01bcb340
https://pubmed.ncbi.nlm.nih.gov/29659796
https://pubmed.ncbi.nlm.nih.gov/29659796
Autor:
Hans-Georg Sahl, Michaele Josten, R. Horré, G. Marklein, Markus Kostrzewa, T. Wenzel, Ursula Klanke, Achim Hoerauf, T. Maier, E. Müller, Gabriele Bierbaum
Publikováno v:
Journal of Clinical Microbiology. 47:2912-2917
The clinical impact of severe infections with yeasts and yeast-like fungi has increased, especially in immunocompromised hosts. In recent years, new antifungal agents with different and partially species-specific activity patterns have become availab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8840be3c9bac2aeaf7e6747cf4344e85
https://doi.org/10.1128/jcm.00389-09
https://doi.org/10.1128/jcm.00389-09